Another Stab At FDA West Nile Virus Screening Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA is issuing a new draft guidance Dec. 15 recommending the use of an FDA-licensed nucleic acid test on living donors of cells, tissue and tissue-based products for evidence of infection with West Nile Virus. It updates from a 2013 draft guidance on the same topic that was never finalized.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.